Motohiro Kato
- Molecular Biology top 5%
- Oncology top 2%
- Neurology top 1%
- Hematology top 1%
- Public Health, Environmental and Occupational Health top 2%
- Co-authors
- Shozo TobimatsuYuichi SugiyamaSeishi OgawaAtsushi ManabeMasashi SanadaJunko TakitaFumio ShimaMinoru Kimura
- Topics
- Acute Lymphoblastic Leukemia research (52 papers)Acute Myeloid Leukemia Research (37 papers)Drug Transport and Resistance Mechanisms (33 papers)
- Cited by
- HematologyPharmacologyNeurology
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Motohiro Kato
330 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Molecular Biology 1.7k
- Oncology 1.3k
- Neurology 1.3k
- Hematology 1.0k
- Public Health, Environmental and Occupational Health 944
Countries citing papers authored by Motohiro Kato
This map shows the geographic impact of Motohiro Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motohiro Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motohiro Kato more than expected).
Fields of papers citing papers by Motohiro Kato
This network shows the impact of papers produced by Motohiro Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motohiro Kato. The network helps show where Motohiro Kato may publish in the future.
Co-authorship network of co-authors of Motohiro Kato
This figure shows the co-authorship network connecting the top 25 collaborators of Motohiro Kato. A scholar is included among the top collaborators of Motohiro Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motohiro Kato. Motohiro Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 5 | |
| 14 | 4 | |
| 15 | 3 | |
| 16 | 3 | |
| 17 | 2 | |
| 18 | Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on | 403 |
| 19 | 71 | |
| 20 | 52 |
About Motohiro Kato
Motohiro Kato is a scholar working on Hematology, Pharmacology and Neurology, having authored 354 papers that have together received 6.8k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (52 papers), Acute Myeloid Leukemia Research (37 papers) and Drug Transport and Resistance Mechanisms (33 papers). The work is most often cited by research in Hematology (1.0k citations), Pharmacology (752 citations) and Neurology (1.3k citations). Motohiro Kato has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Shozo Tobimatsu, Yuichi Sugiyama, Seishi Ogawa, Atsushi Manabe, Masashi Sanada, Junko Takita, Fumio Shima, Minoru Kimura, Shinichi Hosokawa and Yuyan Chen. Their work appears in journals such as Nature, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.